Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Stargardt disease (STGD1) due to mutations in the large ABCA4 gene is the most common inherited macular degeneration in humans. We have shown that dual adeno-associated viral (AAV) vectors effectively transfer ABCA4 to the retina of Abca4-/- mice. However, they express both lower levels of transgene compared with a single AAV and truncated proteins. To increase productive dual AAV concatemerization, which would overcome these limitations, we have explored the use of either various regions of homology or heterologous inverted terminal repeats (ITR). In addition, we tested the ability of various degradation signals to decrease the expression of truncated proteins. We found the highest levels of transgene expression using regions of homology based on either alkaline phosphatase or the F1 phage (AK). The use of heterologous ITR does not decrease the levels of truncated proteins relative to full-length ABCA4 and impairs AAV vector production. Conversely, the inclusion of the CL1 degradation signal results in the selective degradation of truncated proteins from the 5'-half without affecting full-length protein production. Therefore, we developed dual AAV hybrid ABCA4 vectors including homologous ITR2, the photoreceptor-specific G protein-coupled receptor kinase 1 promoter, the AK region of homology and the CL1 degradation signal. We show that upon subretinal administration these vectors are both safe in pigs and effective in Abca4-/- mice. Our data support the use of improved dual AAV vectors for gene therapy of STGD1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In spite of this, the protein expression levels achievable may be sufficient to slow down or stop disease progression [Trapani 2015, McClements 2019].”
From Correcting visual loss by genetics and prosthetics (2020) · cites this paper as Trapani 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though others have detected OL reconstitution in RPE cells, but not photoreceptors, this may be due to differences in overlap lengths and sequences (Trapani et al., 2015).”
From Evaluating Efficiencies of Dual AAV Approaches for Retinal Targeting (2017) · cites this paper as Trapani et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, a general issue of dual/triple AAV vectors is the potential production of aberrant protein products from (i) erroneous reassembly and/or from (ii) the untoward expression of individual split transgenes.”
From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Subretinal administration of AAV2/8 using transsplicing and hybrid vector strategies has shown efficient retinal pigment epithelium and photoreceptor transduction [29,30,101].”
From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When the authors compared three minimal AP HR constructs to the phage F1 HR constructs in HEK293 cells, one of the shortened AP HR vectors (AP1) showed slightly higher expression levels compared with the two other vector systems. 60”
From Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids (2016) · cites this paper as [60]
Experimental — accuracy not yet measured
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statistics and Computing · doi:10.1007/978-0-387-21706-2 · Cited by 24,305
Impairment of the Ubiquitin-Proteasome System by Protein Aggregation
Bence, N. F., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,187
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Self-citationIn Vivo Half-Life of a Protein Is a Function of Its Amino-Terminal Residue
Bachmair, A., Finley, D., & Varshavsky, A. (1986) · Science · doi:10.1126/science.3018930 · Cited by 1,971
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Allikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435 · cited 1×
“Stargardt disease (STGD1; MIM#248200), the most common form of inherited macular degeneration in humans, is caused by mutations in ABCA4 [coding sequence (CDS): 6822 bp], which encodes the photoreceptor (PR)-specific all-trans-retinal transporter (1,2).”
Delori, F. C., Dorey, C. K., Staurenghi, G., Arend, O., Goger, D. G., & Weiter, J. J. (1995) · PubMed · Cited by 948
Weng, J., Mata, N. L., Azarian, S. M., Tzekov, R. T., Birch, D. G., & Travis, G. H. (1999) · Cell · doi:10.1016/s0092-8674(00)80602-9 · Cited by 881 · cited 1×
“Abca4−/−mice (3), the only STGD1 animalmodel, recapitulate some of the features of the human retinal disease including abnormal lipofuscin accumulation in the RPE.”
Maguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61836-5 · Cited by 865
Self-citationSimonelli, F., Maguire, A. M., Testa, F., Pierce, E. A., Mingozzi, F., Bennicelli, J. L., Rossi, S., Marshall, K., Banfi, S., Surace, E. M., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.277 · Cited by 553
Self-citationParish, C. A., Hashimoto, M., Nakanishi, K., Dillon, J., & Sparrow, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14609 · Cited by 474
Auricchio, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3075 · Cited by 403
Self-citationFlotte, T. R., Afione, S. A., Solow, R., Drumm, M. L., Markakis, D., Guggino, W. B., Zeitlin, P. L., & Carter, B. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53762-5 · Cited by 342
Cloning and Characterization of Adeno-Associated Virus Type 5
Chiorini, J. A., Kim, F., Yang, L., & Kotin, R. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1309-1319.1999 · Cited by 332
Cideciyan, A. V., Hauswirth, W. W., Aleman, T. S., Kaushal, S., Schwartz, S. B., Boye, S. L., Windsor, E. A. M., Conlon, T. J., Sumaroka, A., Pang, J.-J., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.086 · Cited by 312
Allocca, M., Doria, M., Petrillo, M., Colella, P., Garcia-Hoyos, M., Gibbs, D., Kim, S. R., Maguire, A., Rex, T. S., Di Vicino, U., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34316 · Cited by 292
Self-citationFinnemann, S. C., Leung, L. W., & Rodriguez-Boulan, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052025899 · Cited by 283
ABCR expression in foveal cone photoreceptors and its role in Stargardt macular dystrophy
Molday, L. L., Rabin, A. R., & Molday, R. S. (2000) · Nature Genetics · doi:10.1038/77004 · Cited by 269 · cited 1×
“As ABCA4 is expressed in both rod and cone photoreceptors in humans (38), we identified a suitable promoter for ABCA4 delivery by comparing the PR transduction properties of single AAV2/8 vectors encoding EGFP from either the human GRK1 or IRBP (interphotoreceptor retinoid binding protein) promoters, which have been b…”
Effective delivery of large genes to the retina by dual AAV vectors
Trapani, I., Colella, P., Sommella, A., Iodice, C., Cesi, G., de Simone, S., Marrocco, E., Rossi, S., Giunti, M., Palfi, A., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201302948 · Cited by 269
Self-citationUbiquitin as a degradation signal.
Johnson, E. S., Bartel, B., Seufert, W., & Varshavsky, A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05080.x · Cited by 263
Duan, D., Yue, Y., & Engelhardt, J. F. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0456 · Cited by 262
Beltran, W. A., Cideciyan, A. V., Lewin, A. S., Iwabe, S., Khanna, H., Sumaroka, A., Chiodo, V. A., Fajardo, D. S., Román, A. J., Deng, W.-T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118847109 · Cited by 260
Degradation signals for ubiquitin system proteolysis in Saccharomyces cerevisiae
Gilon, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2759 · Cited by 227
Biosynthetic Studies of A2E, a Major Fluorophore of Retinal Pigment Epithelial Lipofuscin
Ben-Shabat, S., Parish, C. A., Vollmer, H. R., Itagaki, Y., Fishkin, N., Nakanishi, K., & Sparrow, J. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108981200 · Cited by 214
Heart Failure and Protein Quality Control
Wang, X., & Robbins, J. (2006) · Circulation Research · doi:10.1161/01.res.0000252342.61447.a2 · Cited by 208
Distribution and Density of Medium- and Short-wavelength Selective Cones in the Domestic Pig Retina
Hendrickson, A., & Hicks, D. (2002) · Experimental Eye Research · doi:10.1006/exer.2002.1181 · Cited by 183
Vector platforms for gene therapy of inherited retinopathies
Trapani, I., Puppo, A., & Auricchio, A. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.08.001 · Cited by 183
Self-citationGao, G., Qu, G., Burnham, M. S., Huang, J., Chirmule, N., Joshi, B., Yu, Q.-C., Marsh, J. A., Conceicao, C. M., & Wilson, J. M. (2000) · Human Gene Therapy · doi:10.1089/104303400750001390 · Cited by 174
The Guideline of the Design and Validation of MiRNA Mimics
Wang, Z. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-60761-863-8_15 · Cited by 163
Ghosh, A., Yue, Y., Lai, Y., & Duan, D. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300322 · Cited by 161
miRNeye: a microRNA expression atlas of the mouse eye
Karali, M., Peluso, I., Gennarino, V. A., Bilio, M., Verde, R., Lago, G., Dollé, P., & Banfi, S. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-715 · Cited by 155
Photoreceptor density of the domestic pig retina
Chandler, Smith, Samuelson, & Mackay (1999) · Veterinary Ophthalmology · doi:10.1046/j.1463-5224.1999.00077.x · Cited by 141
Khani, S. C., Pawlyk, B. S., Bulgakov, O. V., Kasperek, E., Young, J. E., Adamian, M., Sun, X., Smith, A. J., Ali, R. R., & Li, T. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0257 · Cited by 139
Dyka, F. M., Boye, S. L., Chiodo, V. A., Hauswirth, W. W., & Boye, S. E. (2014) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.212 · Cited by 128 · cited 2×
“A second major issue associated with the use of dual AAV vectors is the production of truncated proteins from the 5′-half vector that contains the promoter sequence and/or from the 3′-half vector due to the low promoter activity of the inverted terminal repeats (ITR) (10,13,16,17).”
Zhang, Y., Chirmule, N., Gao, G.-P., & Wilson, J. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8003-8010.2000 · Cited by 119
Boye, S. E., Alexander, J. J., Boye, S. L., Witherspoon, C. D., Sandefer, K. J., Conlon, T. J., Erger, K., Sun, J., Ryals, R., Chiodo, V. A., et al. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.125 · Cited by 117
Retinal gene therapy with a large MYO7A cDNA using adeno-associated virus
Lopes, V. S., Boye, S. E., Louie, C. M., Boye, S., Dyka, F., Chiodo, V, Fofo, H., Hauswirth, W. W., & Williams, D. S. (2013) · Gene Therapy · doi:10.1038/gt.2013.3 · Cited by 112
MicroRNAs in vitreus humor from patients with ocular diseases.
Ragusa, M., Caltabiano, R., Russo, A., Puzzo, L., Avitabile, T., Longo, A., Toro, M. D., Pietro, C. D., Purrello, M., & Reibaldi, M. (2013) · PubMed Central · Cited by 108
Yan, Z., Zak, R., Zhang, Y., & Engelhardt, J. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.364-379.2005 · Cited by 107
Fundus autofluorescence and the bisretinoids of retina
Sparrow, J. R., Wu, Y., Nagasaki, T., Yoon, K. D., Yamamoto, K., & Zhou, J. (2010) · Photochemical & Photobiological Sciences · doi:10.1039/c0pp00207k · Cited by 106
Koo, T., Popplewell, L., Athanasopoulos, T., & Dickson, G. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.164 · Cited by 104
Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors
Colella, P., Trapani, I., Cesi, G., Sommella, A., Manfredi, A., Puppo, A., Iodice, C., Rossi, S., Simonelli, F., Giunti, M., et al. (2014) · Gene Therapy · doi:10.1038/gt.2014.8 · Cited by 103 · cited 4×
“CL1 degron in the pig retina, which has a size and structure similar to human (15,26,36,37) and is therefore an excellent pre-clinical large animal model to evaluate vector safety and efficiency.”
InfluentialSelf-citationAAV-mediated photoreceptor transduction of the pig cone-enriched retina
Mussolino, C., della Corte, M., Rossi, S., Viola, F., Di Vicino, U., Marrocco, E., Neglia, S., Doria, M., Testa, F., Giovannoni, R., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.3 · Cited by 102
Self-citationFundus Autofluorescence and RPE Lipofuscin in Age-Related Macular Degeneration
Sparrow, J. R., & Duncker, T. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041302 · Cited by 98
Reich, S. J., Auricchio, A., Hildinger, M., Glover, E., Maguire, A. M., Wilson, J. M., & Bennett, J. (2003) · Human Gene Therapy · doi:10.1089/10430340360464697 · Cited by 96 · cited 1×
“However, recently, several groups, including ours, have independently reported effective delivery of large genes to both the mouse and pig retina by dual AAV vectors (10,13,15,44), thus expanding their applicability to diseases like STGD1 due to mutations in genes with a CDS which exceeds the canonical AAV cargo capac…”
Self-citationGhosh, A., Yue, Y., & Duan, D. (2011) · Human Gene Therapy · doi:10.1089/hum.2010.122 · Cited by 95
Defective lipid transport and biosynthesis in recessive and dominant Stargardt macular degeneration
Molday, R. S., & Zhang, K. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.002 · Cited by 82 · cited 2×
“Consequently, abnormally high levels of lipofuscin pigments, such as A2E and all-transretinal dimer-phosphatidylethanolamine, accumulate in the RPE, triggering RPE-cell death and causing secondary PR degeneration (2).”
Chiorini, J. A., Afione, S., & Kotin, R. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4293-4298.1999 · Cited by 78
Full-Length Dystrophin Reconstitution with Adeno-Associated Viral Vectors
Lostal, W., Kodippili, K., Yue, Y., & Duan, D. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.210 · Cited by 77
Intraocular Delivery of Recombinant Virus
Liang, F.-Q., Anand, V., Maguire, A. M., & Bennett, J. (2003) · Vision Research Protocols · doi:10.1385/1-59259-085-3:125 · Cited by 68
Kutty, R. K., Samuel, W., Jaworski, C. J., Duncan, T. E., Nagineni, C. N., Raghavachari, N., Wiggert, B. O., & Redmond, T. M. (2010) · PubMed Central · Cited by 68
Li, A., Zhu, X., Brown, B., & Craft, C. M. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0434 · Cited by 64
Synthetic Signals for Ubiquitin-Dependent Proteolysis
Sadis, S., Atienza, C., & Finley, D. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4086 · Cited by 62
Gargiulo, A., Bonetti, C., Montefusco, S., Neglia, S., Di Vicino, U., Marrocco, E., Corte, M. D., Domenici, L., Auricchio, A., & Surace, E. M. (2009) · Molecular Therapy · doi:10.1038/mt.2009.112 · Cited by 61
Self-citationPoly(A)-binding protein modulates mRNA susceptibility to cap-dependent miRNA-mediated repression
Walters, R. W., Bradrick, S. S., & Gromeier, M. (2010) · RNA · doi:10.1261/rna.1795410 · Cited by 61
MicroRNA-Restricted Transgene Expression in the Retina
Karali, M., Manfredi, A., Puppo, A., Marrocco, E., Gargiulo, A., Allocca, M., Corte, M. D., Rossi, S., Giunti, M., Bacci, M. L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022166 · Cited by 60
Self-citationThe physiological impact of microRNA gene regulation in the retina
Sundermeier, T. R., & Palczewski, K. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0976-7 · Cited by 59
Doria, M., Ferrara, A., & Auricchio, A. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.155 · Cited by 56
Self-citationHigh-Throughput Functional MicroRNAs Profiling by Recombinant AAV-Based MicroRNA Sensor Arrays
Tian, W., Dong, X., Liu, X., Wang, G., Dong, Z., Shen, W., Zheng, G., Lü, J., Chen, J., Wang, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029551 · Cited by 56
Gargiulo, S., Greco, A., Gramanzini, M., et al. (2012) · ILAR Journal · doi:10.1093/ilar.53.1.70 · Cited by 56
High throughput production, screening and analysis of adeno-associated viral vectors
Drittanti, L., Rivet, C., Manceau, P., Danos, O., & Vega, M. T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301191 · Cited by 48
Li, A., Zhu, X., & Craft, C. M. (2002) · PubMed · Cited by 47
Young, J. E., Vogt, T., Gross, K. W., & Khani, S. C. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0197 · Cited by 47
Fundus Autofluorescence Findings in a Mouse Model of Retinal Detachment
Secondi, R., Kong, J., Blonska, A. M., Staurenghi, G., & Sparrow, J. R. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9672 · Cited by 44
Testa, F., Surace, E. M., Rossi, S., Marrocco, E., Gargiulo, A., Di Iorio, V., Ziviello, C., Nesti, A., Fecarotta, S., Bacci, M. L., et al. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6543 · Cited by 44
Self-citationCombined Rod and Cone Transduction by Adeno-Associated Virus 2/8
Manfredi, A., Marrocco, E., Puppo, A., Cesi, G., Sommella, A., Della Corte, M., Rossi, S., Giunti, M., Craft, C. M., Bacci, M. L., et al. (2013) · Human Gene Therapy · doi:10.1089/hum.2013.154 · Cited by 43
Self-citationAllocca, M., Manfredi, A., Iodice, C., Di Vicino, U., & Auricchio, A. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6269 · Cited by 42
Self-citationRicci, E. P., Limousin, T., Soto‐Rifo, R., Allison, R. J., Pöyry, T. A. A., Décimo, D., Jackson, R. J., & Ohlmann, T. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr086 · Cited by 42
Yan, Z., Lei-Butters, D. C. M., Zhang, Y., Zak, R., & Engelhardt, J. F. (2007) · Human Gene Therapy · doi:10.1089/hum.2006.128 · Cited by 41 · cited 4×
“higher transduction efficiency than vectors with homologous ITRs and apparently no production issues (20,21).”
InfluentialMelatonin Enhances Retinoic Acid Induction of Cone Arrestin Gene Expression in Retinoblastoma Cells
Li, A., Zhu, X., Brown, B., & Craft, C. M. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0067-4_46 · Cited by 4
Research works printed but not linked: 1
- Sambrook, 2001, Molecular Cloning: A Laboratory Manual
Cited by
Emerging issues in AAV-mediated in vivo gene therapy
Colella, P., Ronzitti, G., & Mingozzi, F. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.007 · Cited by 881
Self-citationAAV vectors: The Rubik’s cube of human gene therapy
Pupo, A., Fernández, A., Low, S. H., François, A., Suárez-Amarán, L., & Samulski, R. J. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.09.015 · Cited by 360
Cremers, F. P. M., Lee, W., Collin, R. W. J., & Allikmets, R. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100861 · Cited by 315
Tornabene, P., Trapani, I., Minopoli, R., Centrulo, M., Lupo, M., de Simone, S., Tiberi, P., Dell’Aquila, F., Marrocco, E., Iodice, C., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav4523 · Cited by 192
Self-citationExpressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids
Chamberlain, K., Riyad, J. M., & Weber, T. (2016) · Human Gene Therapy Methods · doi:10.1089/hgtb.2015.140 · Cited by 141
Metadata
- Authors
- Trapani, I., Toriello, E., de Simone, S., Colella, P., Iodice, C., Polishchuk, E. V., Sommella, A., Colecchi, L., Rossi, S., Simonelli, F., Giunti, M., Bacci, M. L., Polishchuk, R. S., & Auricchio, A.
- Affiliations
- Telethon Institute Of Genetics And Medicine (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- University of Bologna (IT)
- Federico II University Hospital (IT)
- Corresponding author
- Auricchio, Alberto
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-09-29
- Volume
- 24
- Issue
- 23
- Pages
- 6811-6825
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC4634381
- OpenAlex
- W2172376325
- Cited by
- 94
- References
- 70
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 2 · 2023: 9 · 2022: 9 · 2021: 13 · 2020: 10 · 2019: 8 · 2018: 9 · 2017: 11 · 2016: 6
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Human Molecular Genetics (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by-nc)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Funders
- European Research Council/ERC (282085)
- Italian Telethon Foundation (TGM11MT1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- Stargardt disease, ABCA4, adeno-associated virus gene therapy, inverted terminal repeats, degradation signals, subretinal gene delivery
- MeSH terms
- Stargardt Disease, Dependovirus, Animals, Disease Models, Animal, Female, Genetic Vectors, Humans, Macular Degeneration, Retina, Swine, Genetic Therapy, ATP-Binding Cassette Transporters, Transgenes, Terminal Repeat Sequences, Mice, HEK293 Cells, Administration, Ophthalmic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.